Top Markets
Coin of the day
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation

ADMP
주식 순위 #38725
Adamis Pharmaceuticals Corporation is a specialized biopharmaceutical company... Adamis Pharmaceuticals Corporation is a specialized biopharmaceutical company primarily engaged in the development and commercialization of products within the United States, targeting key therapeutic domains such as allergy, opioid overdose, respiratory conditions, and inflammatory diseases. Its current product portfolio includes SYMJEPI pre-filled epinephrine syringes for the emergency treatment of severe allergic reactions, including anaphylaxis; dry powder inhaler products designed for asthma management; and injectable naloxone for addressing opioid overdose. Additionally, Adamis is advancing pipeline candidates such as APC400, a tempol gel aimed at mitigating radiation-induced dermatitis in cancer patients, and APC410, formulated to treat a range of respiratory ailments including asthma, respiratory syncytial virus (RSV), influenza, and COVID-19. The company also extends its offerings to include corticosteroids, hormone replacement therapies, hospital outsourcing products, and other injectables, alongside a line of veterinary pharmaceutical products. Established in 2006, Adamis Pharmaceuticals Corporation maintains its headquarters in San Diego, California.
주가
$0.6241
마지막 동기화: 2023-10-03
시가총액
$836.88K
변동 (1일)
-2.10%
변동 (1년)
0.00%
국가
US
거래 Adamis Pharmaceuticals Corporation (ADMP)

카테고리

Adamis Pharmaceuticals Corporation (ADMP)의 주식 분할 이력
Adamis Pharmaceuticals Corporation 주식 (심볼: ADMP)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 14, 2026에 발생했습니다.
Aug 14, 2026 이전에 매수한 ADMP 주식 1주는 현재 0주의 ADMP 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할